Podcasts about associate director

In 2020, Cameron transitioned into the collegiate ranks, serving as Associate Director of Football Performance at the University of North Carolina at Charlotte before moving to Indiana University as an Athletic Performance Coach for football, where he remained through 2023. From there, he joined Auburn University as an Assistant Strength & Conditioning Coach, working with one of the most competitive programs in the SEC. Today, Cameron continues that trajectory at the highest level of the game as an Assistant Strength & Conditioning Coach for the Detroit Lions. A former defensive back at the University of Rhode Island, Cameron holds a bachelor's degree in kinesiology, a master's in exercise science from William Paterson University, and is currently a PhD candidate at Jean Monnet University in Saint-Etienne, France. His academic pursuits, paired with years of practical experience, shape a coaching philosophy that balances evidence-based performance science with the demands of real-world competition. Cameron's ability to adapt programming across sports and athlete needs has made him a trusted resource in the world of strength and conditioning. Whether building a foundation for young athletes or optimizing peak performance for professionals on game day, his long-term approach centers on developing strength, speed, resilience, and durability that lasts throughout an athlete's career. THANK YOU TO THIS EPISODE'S SPONSORS - Support Massenomics! https://www.massenomics.com/ - Use the discount code ELITEFTS20 to save 20% on your next monthly, yearly, or lifetime MASS Research Review membership plan. The discount lasts FOREVER!  https://massresearchreview.com/

Over its first century The Guggenheim Fellowships have supported more than 19,000 artists, writers, thinkers, scientists, and makers of ideas and culture in America. In honor of this milestone, The Guggenheim Fellowship at 100, on view at The New York Historical Society through November 30th, shows off correspondence, application materials, cultural objects, and other signs and tokens of what Guggenheim these fellowships and fellows have done. In this episode, Jeff talks to Guggenheim President Edward Hirsch about the fellowships and what they mean. Then, Hanna Pennington, Associate Director and Archivist at the Guggenheim, joins to talk about the work and materials that went into making this exhibition. Subscribe to First Edition via RSS, Apple Podcasts, or Spotify. For episode extras, subscribe to the First Edition Substack. Learn more about your ad choices. Visit megaphone.fm/adchoices

Steven Shein, MD, FCCM, is the Chief of Pediatric Critical Care at University Hospitals Rainbow Babies & Children's Hospital in Cleveland, Ohio, and holds the Linsalata Family Distinguished Chair in Pediatric Critical Care and Emergency Medicine. He is also the Co-Director of the PICU Clinical, Basic & Translational Research Program and an Associate Director of the Pediatric Critical Care Medicine Fellowship program. His research focuses on critical bronchiolitis and long-term neuro-cognitive morbidity after critical illness. Jatinder Dhami, MD, is a Pediatric Intensivist at University Hospitals Rainbow Babies & Children's Hospital in Cleveland, Ohio. She completed her pediatrics residency at Penn State in Hershey, PA, and her PICU fellowship at Riley Children's Hospital in Indianapolis, Indiana. She is interested in clinical ethics in pediatric critical illness.Learning Objective:By the end of this podcast, listeners should be able to discuss an evidence-based and expert-guided approach to managing critical bronchiolitis.References:Managing Critical Bronchiolitis David G. Speicher, MD; and Steven L. Shein, MD, FCCMZurca et al. Management of Critical Bronchiolitis. Hosp Pediatr. 2023Plint et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009.Schramm et al. Clinical Examination Does Not Predict Response to Albuterol in Ventilated Infants With Bronchiolitis. Pediatr Crit Care Med. 2017Shein at al. Antibiotic Prescription in Young Children With Respiratory Syncytial Virus-Associated Respiratory Failure and Associated Outcomes. Pediatr Crit Care Med. 2019.Gelbart et al. Pragmatic Randomized Trial of Corticosteroids and Inhaled Epinephrine for Bronchiolitis in Children in Intensive Care. J Pediatr. 2022.Shein et al. Derivation and Validation of an Objective Effort of Breathing Score in Critically Ill Children. Pediatr Crit Care Med. 2019.Shein SL, Rotta AT. Long-term NeurocognitQuestions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Matthew Hoh is a former USMC Captain, State Department Officer and Associate Director for the Eisenhower Media Network. He talks Sec. of War Pete Hegseth's speech this past week, deployment of the National Guard, narrative formed from the Charlie Kirk assassination, future of Gaza, and much more. PLEASE SUBSCRIBE LIKE AND SHARE THIS PODCAST!!!    Watch Show Rumble- https://rumble.com/v6zuq0e-sec.-of-war-hegseth-is-about-images-and-optics-matthew-hoh.html YouTube- https://youtu.be/bmhbkfNfNPk   Follow Me X- https://x.com/CoffeeandaMike IG- https://www.instagram.com/coffeeandamike/ Facebook- https://www.facebook.com/CoffeeandaMike/ YouTube- https://www.youtube.com/@Coffeeandamike Rumble- https://rumble.com/search/all?q=coffee%20and%20a%20mike Substack- https://coffeeandamike.substack.com/ Apple Podcasts- https://podcasts.apple.com/us/podcast/coffee-and-a-mike/id1436799008 Gab- https://gab.com/CoffeeandaMike Locals- https://coffeeandamike.locals.com/ Website- www.coffeeandamike.com Email- info@coffeeandamike.com   Support My Work Venmo- https://www.venmo.com/u/coffeeandamike Paypal- https://www.paypal.com/biz/profile/Coffeeandamike Substack- https://coffeeandamike.substack.com/ Patreon- http://patreon.com/coffeeandamike Locals- https://coffeeandamike.locals.com/ Cash App- https://cash.app/$coffeeandamike Buy Me a Coffee- https://buymeacoffee.com/coffeeandamike Bitcoin- coffeeandamike@strike.me   Mail Check or Money Order- Coffee and a Mike LLC P.O. Box 25383 Scottsdale, AZ 85255-9998   Follow Matthew X- https://x.com/MatthewPHoh Substack- https://substack.com/@matthewhoh Website- https://eisenhowermedianetwork.org/about/   Sponsors Vaulted/Precious Metals- https://vaulted.blbvux.net/coffeeandamike McAlvany Precious Metals- https://mcalvany.com/coffeeandamike/

Mickal Lewis, Associate Director of the Center of Excellence on Dementia Risk Reduction with the Alzheimer's Association, shares how Community Health Workers play an essential role supporting a continuum of care for community members with dementia, and how public health leaders can help advance progress; Jeffrey Ekoma, Senior Director of Government Affairs at ASTHO, provides an update on the current government shutdown and explains how federal health agencies are impacted in this week's View from Washington, D.C. report; a new ASTHO report provides key resources that can help state and territorial health departments break down silos and collaborate with their partners in Medicaid agencies to improve health outcomes in their communities; and Dr. Susan Kansagra, Chief Medical Officer at ASTHO, was recently quoted in a story for STAT Health about low-income children's lack of access to the Covid-19 vaccine.  Frontiers in Public Health Research Article: Community health workers: developing roles in public health dementia efforts in the United States ASTHO Legislative Alert: Federal Government Shutdown Update: Contingency Plans Released ASTHO Report: Leveraging Public Health Assets in Medicaid Managed Care STAT Health: Low-income children lack access to Covid vaccines because of approval delay  

As part of our ongoing collaboration with Central Square Foundation, we are here with the third episode of our five part series where we talk about public disclosure of school learning quality data.Usually, when parents assess schools for their children, they focus on non-academic factors like infrastructure and school facilities. But they do not have access to information regarding the most important factor that is student learning quality. The National Education Policy 2020 places a strong emphasis on public disclosure of school performance. To understand how is this reform is being implemented, we'll be joined by two guests who have been working hard towards bringing this change, Kapil Khurana, Associate Director for School Governance at CSF and A.K. Modh Patel, Additional Director, GCERT, Gujarat who is leading Gujarat's effort to disclose school learning quality data through the School Quality Assessment and Assurance Framework (SQAAF).Hosted and produced by Niharika NandaEdited and mixed by Suresh PawarLink to the first and second episode of our series with CSF:Episode 1Episode 2

Carla L. Spagnoletti, MD, MS, has some promotion portfolio gems of wisdom for our listeners in her return to the Faculty Factory Podcast this week. At the University of Pittsburgh School of Medicine, Dr. Spagnoletti serves as Professor of Medicine and holds the George H. Taber Endowed Chair in General Internal Medicine. In addition, she is the Associate Dean for Faculty Affairs, the Associate Division Chief for Education in GIM, and the Associate Director of the Masters and Certificate Programs in Medical Education within the Institute for Clinical Research Education. As discussed in this interview, there are many reasons why clinical faculty should seek promotion. However, clinical faculty often climb the ranks more slowly than their research counterparts. While Dr. Spagnoletti concedes that this is probably due to multiple factors—such as rigorous and competing clinical duties, a lack of understanding of the process, and not always seeing tangible incentives for pursuing promotion—it became clear that something needed to be done. Therefore, Dr. Spagnoletti set out to help faculty overcome the final hurdle in promotion: building a promotion dossier or portfolio. She helped form a supportive group to assist faculty in submitting and building this portfolio so they can initiate the promotion process. At her institution, this group is called the Promotion Portfolio Club (PPC). As a true clinician-educator, she designed it as a curriculum based on a few core theories commonly used in medical education. “One of the participants in a recent club told us, ‘I'm eternally grateful, as I can only imagine this task would have been incredibly daunting had I gone it alone,' and that really captures the main reason why we started this project,” she said. Learn more: https://facultyfactory.org/ 

Osteosarcoma Webinar Series: Alanna Church, MD, Associate Director, Laboratory for Molecular Pediatric Pathology at Boston Children's Hospital, Assistant Professor of Pathology at Harvard Medical School, and Conference Cochair joins us on OsteoBites to discuss insights and higlights from the AACR Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer—From Biology to Breakthrough Therapies, September 25-28 in Boston.Dr. Church is currently a Molecular and Pediatric Pathologist at Boston Children's Hospital, where she is a founder and associate medical director of the Laboratory for Molecular Pediatric Pathology (LaMPP). She is an Assistant Professor of Pathology at Harvard Medical School, the Program Director for the Harvard Molecular Genetic Pathology Fellowship, and the incoming Chair of Clinical Practice for the Association for Molecular Pathology. Her clinical and research work focuses on bringing molecular testing to the clinical care of children with cancer. Through institutional projects (the Profile study, GAIN consortium study), she has profiled thousands of children's tumors and has used these results to make real-time impacts on their diagnoses and treatments. She is involved in national initiatives to improve the quality and access to molecular testing for children with cancer, including the NCI-funded Count Me In Study (Dana Farber, Broad Institute), the National Comprehensive Cancer Network, the National Institutes of Health, and the Children's Oncology Group.

In this episode recorded live at the McGuireWoods Healthcare Growth & Operations conference, Nina Williams, Associate Director of Mount Sinai Ventures, discusses how the health system is expanding its ambulatory footprint and investing in early stage companies. She shares insights on strategic partnerships, innovation trends, and advice for emerging healthcare leaders.

In this episode recorded live at the McGuireWoods Healthcare Growth & Operations conference, Nina Williams, Associate Director of Mount Sinai Ventures, discusses how the health system is expanding its ambulatory footprint and investing in early stage companies. She shares insights on strategic partnerships, innovation trends, and advice for emerging healthcare leaders.

******Support the channel******Patreon: https://www.patreon.com/thedissenterPayPal: paypal.me/thedissenterPayPal Subscription 1 Dollar: https://tinyurl.com/yb3acuuyPayPal Subscription 3 Dollars: https://tinyurl.com/ybn6bg9lPayPal Subscription 5 Dollars: https://tinyurl.com/ycmr9gpzPayPal Subscription 10 Dollars: https://tinyurl.com/y9r3fc9mPayPal Subscription 20 Dollars: https://tinyurl.com/y95uvkao ******Follow me on******Website: https://www.thedissenter.net/The Dissenter Goodreads list: https://shorturl.at/7BMoBFacebook: https://www.facebook.com/thedissenteryt/Twitter: https://x.com/TheDissenterYT This show is sponsored by Enlites, Learning & Development done differently. Check the website here: http://enlites.com/ Dr. Melissa Shew Dr. Melissa Shew is currently the Associate Director of Teaching Excellence at Marquette University, where she is also the Faculty Director of their Executive MBA Program.Dr. Kimberly Garchar is Associate Professor of Philosophyat Kent State University.They are authors of Philosophy for Girls: An Invitation to the Life of Thought. In this episode, we focus on Philosophy for Girls. We talk about the premise of the book, what a philosophy for girls is and why it matters, the difference between sex and gender, the issue of under-representation of women in philosophy, and the gender gap in academic philosophy. We also discuss whether the way philosophy is done is gendered, the topics of the book, whether women can be empowered through philosophy, and how the gender gap can be addressed.--A HUGE THANK YOU TO MY PATRONS/SUPPORTERS: PER HELGE LARSEN, JERRY MULLER, BERNARDO SEIXAS, ADAM KESSEL, MATTHEW WHITINGBIRD, ARNAUD WOLFF, TIM HOLLOSY, HENRIK AHLENIUS, ROBERT WINDHAGER, RUI INACIO, ZOOP, MARCO NEVES, COLIN HOLBROOK, PHIL KAVANAGH, SAMUEL ANDREEFF, FRANCIS FORDE, TIAGO NUNES, FERGAL CUSSEN, HAL HERZOG, NUNO MACHADO, JONATHAN LEIBRANT, JOÃO LINHARES, STANTON T, SAMUEL CORREA, ERIK HAINES, MARK SMITH, JOÃO EIRA, TOM HUMMEL, SARDUS FRANCE, DAVID SLOAN WILSON, YACILA DEZA-ARAUJO, ROMAIN ROCH, DIEGO LONDOÑO CORREA, YANICK PUNTER, CHARLOTTE BLEASE, NICOLE BARBARO, ADAM HUNT, PAWEL OSTASZEWSKI, NELLEKE BAK, GUY MADISON, GARY G HELLMANN, SAIMA AFZAL, ADRIAN JAEGGI, PAULO TOLENTINO, JOÃO BARBOSA, JULIAN PRICE, HEDIN BRØNNER, DOUGLAS FRY, FRANCA BORTOLOTTI, GABRIEL PONS CORTÈS, URSULA LITZCKE, SCOTT, ZACHARY FISH, TIM DUFFY, SUNNY SMITH, JON WISMAN, WILLIAM BUCKNER, PAUL-GEORGE ARNAUD, LUKE GLOWACKI, GEORGIOS THEOPHANOUS, CHRIS WILLIAMSON, PETER WOLOSZYN, DAVID WILLIAMS, DIOGO COSTA, ALEX CHAU, AMAURI MARTÍNEZ, CORALIE CHEVALLIER, BANGALORE ATHEISTS, LARRY D. LEE JR., OLD HERRINGBONE, MICHAEL BAILEY, DAN SPERBER, ROBERT GRESSIS, JEFF MCMAHAN, JAKE ZUEHL, BARNABAS RADICS, MARK CAMPBELL, TOMAS DAUBNER, LUKE NISSEN, KIMBERLY JOHNSON, JESSICA NOWICKI, LINDA BRANDIN, VALENTIN STEINMANN, ALEXANDER HUBBARD, BR, JONAS HERTNER, URSULA GOODENOUGH, DAVID PINSOF, SEAN NELSON, MIKE LAVIGNE, JOS KNECHT, LUCY, MANVIR SINGH, PETRA WEIMANN, CAROLA FEEST, MAURO JÚNIOR, 航 豊川, TONY BARRETT, NIKOLAI VISHNEVSKY, STEVEN GANGESTAD, TED FARRIS, HUGO B., JAMES, JORDAN MANSFIELD, AND CHARLOTTE ALLEN!A SPECIAL THANKS TO MY PRODUCERS, YZAR WEHBE, JIM FRANK, ŁUKASZ STAFINIAK, TOM VANEGDOM, BERNARD HUGUENEY, CURTIS DIXON, BENEDIKT MUELLER, THOMAS TRUMBLE, KATHRINE AND PATRICK TOBIN, JONCARLO MONTENEGRO, NICK GOLDEN, CHRISTINE GLASS, IGOR NIKIFOROVSKI, AND PER KRAULIS!AND TO MY EXECUTIVE PRODUCERS, MATTHEW LAVENDER, SERGIU CODREANU, ROSEY, AND GREGORY HASTINGS!

In this episode recorded live at the McGuireWoods Healthcare Growth & Operations conference, Nina Williams, Associate Director of Mount Sinai Ventures, discusses how the health system is expanding its ambulatory footprint and investing in early stage companies. She shares insights on strategic partnerships, innovation trends, and advice for emerging healthcare leaders.

ICYMI: Hour Two of ‘Later, with Mo'Kelly' Presents – Regular guest contributor & Associate Director of Communications for VIZIO, Chris Woolsey joins the program to share the latest offerings from VIZIO's ‘Watch Free+' including FREE Terror Titles with “Train to Busan,” “Terrifier 1 & 2 (2016, 2022)” and “Night of the Living Dead” & FREE Action Flix with “Wrath of the Titans,” “The A-Team” and “Max Payne”…PLUS – Thoughts on a man that claims to be Colonel Sanders' great-great-great-nephew who leaked the secret chicken recipe after KFC blocked him AND a look at a new study that reveals some interesting facts about people who listen to same songs on repeat - on KFI AM 640…Live everywhere on the iHeartRadio app & YouTube @MrMoKelly

Faculty adoption and use of AI in higher education varies widely. In this episode, three colleagues from the University of Mississippi: Josh Eyler, Emily Pitts Donahoe, and Marc Watkins, provide their perspectives on AI use in higher education. Josh is the Senior Director of Center for Excellence in Teaching and Learning and Assistant Professor of Teacher Education, Emily is the Associate Director of Instructional Support in the Center for Excellence in Teaching and Learning and Lecturer of Writing and Rhetoric, and Marc is a Lecturer in Composition and Rhetoric and Assistant Director of Academic Innovation. A transcript of this episode and show notes may be found at http://teaforteaching.com.

Mark talks with Matt Oney about his introduction to modeling instruction and how he uses modeling methodology in the university setting. They talk about the importance of fostering, as opposed to squashing, the curiosity that all children have. Modeling instruction is designed to train students to use their curiosity to pursue answers, and students are engaged in that learning. Additionally, they discuss ways that teachers may be inadvertently killing students' curiosity. They talk about the importance of modeling the student-centered approach in the professional development that we offer to teachers because we want their classrooms to be student-centered. Guest Matt Oney Matt Oney is the Associate Director for Integrated Secondary Science at Michigan State University in the Center for Integrated Studies in General Sciences. His primary focus is on preparing future science educators. In addition, he is the College of Natural Science coordinator for the Certification in College Teaching Program. Matt earned master's degrees in plant biology and education from MSU. Prior to joining MSU as a faculty member, Matt was a high school chemistry and physics teacher in the Upper Peninsula. Highlights [2:33] Matt Oney: "what the myth busters are currently doing of just like taking these general curiosities that they have about the world and identifying ways that they can answer those curiosities. I was like, that's what I want my students to do. But I had no idea how to do that related to physics." [23:42] Matt Oney: "I would argue that all subject matters should be inquiry based and that our students should be learning through their own curiosities," [25:13] Matt Oney: "Learning is not necessarily, fun. It's challenging, but it's engaging. And we have such a huge responsibility to make sure that we are not killing the curiosity of our students." Resources Download Transcript Ep 73 Transcript

ICYMI: ‘Later, with Mo'Kelly' Presents – Regular guest contributor & Associate Director of Communications for VIZIO, Chris Woolsey joins the program to share the latest offerings from VIZIO's ‘Watch Free+' including FREE Terror Titles with “Train to Busan,” “Terrifier 1 & 2 (2016, 2022)” and “Night of the Living Dead” & FREE Action Flix with “Wrath of the Titans,” “The A-Team” and “Max Payne” - on KFI AM 640…Live everywhere on the iHeartRadio app & YouTube @MrMoKelly

In this chapter of Always on EM, Dr. Lacey Shiue, Associate Director of Emergency Ultrasound for Mayo Clinic Emergency Medicine in Rochester, challenges us to recognize the morbidity and mortality associated with rib fractures and to rethink the way we consider pain management for people suffering these injuries.   CONTACTS X - @AlwaysOnEM; @VenkBellamkonda YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch; @Lacey.Shiue Email - AlwaysOnEM@gmail.com  

In this episode of Occupied Thoughts, FMEP Fellow Hilary Rantisi speaks with analyst Mouin Rabbani about political and diplomatic developments relating to the Israeli genocide in Gaza. They discuss the "20 Point Plan" that President Donald Trump released today, as well as his joint press conference with Israeli Prime Minister Benjamin Netanyahu, asking about actual provisions to limit Israel's genocidal behavior and noting the colonial structure of the internationally-headed "Board of Peace" that will rule Gaza, according to the proposal. They discuss the symbolic measure of many countries recognizing Palestinian statehood at the UN last week; Mouin notes that this recognition is the first time that Western governments have taken steps for Palestinians in response to pressure from their own constituencies, and suggests that this action demonstrates that popular pressure can affect policy. Finally, Hilary and Mouin look at current initiatives, including the "United for Peace" proposal and the Gaza Sumud Flotilla, that aim to intervene directly in the genocide.  Mouin Rabbani is a nonresident fellow at the Middle East Council on Global Affairs. He is a researcher, analyst, and commentator specializing in Palestinian affairs, the Arab-Israeli conflict, and contemporary Middle East issues. Among other previous positions, Rabbani served as principal political affairs officer with the Office of the UN Special Envoy of the Secretary-General for Syria, head of the Middle East unit with the Martti Ahtisaari Peace Foundation, and senior Middle East analyst and special advisor on Israel-Palestine with the International Crisis Group. He was also a researcher with Al-Haq, the West Bank affiliate of the International Commission of Jurists.  Rabbani is a co-editor of Jadaliyya, where he also hosts the Connections podcast and edits its Quick Thoughts feature. He is also the managing editor and associate editor of the Journal of Peacebuilding and Development and a contributing editor of Middle East Report. In addition, Rabbani is a nonresident fellow at the Center for Conflict and Humanitarian Studies (CHS) and at Democracy for the Arab World Now (DAWN).  Hilary Rantisi grew up in Palestine and has been involved with education and advocacy on the Middle East since her move to the US. She is a 2025 Fellow at FMEP and was most recently the Associate Director of the Religion, Conflict and Peace Initiative (RCPI) and co-instructor of Learning in Context: Narratives of Displacement and Belonging in Israel/Palestine at Harvard Divinity School. She has over two decades of experience in institution building at Harvard, having been the Director of the Middle East Initiative (MEI) at Harvard Kennedy School of Government prior to her current role. She has a BA in Political Science/International Studies from Aurora University and a master's degree in Middle Eastern Studies from the University of Chicago. Before moving to the US, Hilary worked at Birzeit University and at the Jerusalem-based Sabeel Ecumenical Liberation Theology Center. There, she co-edited a photo essay book Our Story: The Palestinians with the Rev. Naim Ateek.

"From the Frontlines" is an ADL podcast which brings listeners to the frontline in the battle against antisemitism and hate through conversations with ADL staff who are living that battle every day. According to a recent ADL survey, a significant number of Jewish faculty members have considered leaving their positions. One in three has experienced antisemitic incidents on their own campuses. Seventy-three percent report that antisemitism has worsened since October 7th. And many are staying silent about their Jewish identity out of fear for their careers and safety. This is the stark reality revealed by this groundbreaking new Faculty Survey conducted jointly by ADL and the Academic Engagement Network (AEN) - the first comprehensive national study examining the experiences of Jewish faculty in American higher education. The guest for this show is Masha Zemtsov, ADL's Associate Director for Advocacy. Masha has been instrumental in developing ADL's response to campus antisemitism and worked closely with AEN on this groundbreaking research, speaking directly with faculty members who are experiencing these troubling incidents firsthand. To read the full survey results, visit: https://www.adl.org/resources/report/faculty-under-fire-antisemitism-and-anti-israel-bias-higher-education. This conversation was recorded in September 2025.

We challenge contemporary perceptions of Yemen as a "backwater" by revealing the pivotal role of its port city, Mocha, in the making of our modern world. Historian Nancy Um delves into the fascinating history of coffee, from its origins in 15th-century Yemen to its global spread and the economic transformations it spurred. She explores the rich maritime trade routes of the Indian Ocean, highlighting Yemen's centrality as a crossroads for goods, ideas, and people long before European influence. Um discusses the Ottoman Empire's cultivation of coffee in Yemen, the rise and decline of Mocha as a trade hub, and the unique cultural adaptations of coffee consumption within Yemen itself, such as the popular Qishr drink. We also touch upon the broader impact of hot beverages and porcelain on global social and consumption patterns, revealing how these everyday items were once revolutionary technologies. Um shares insights into the ongoing efforts to revive Yemen's coffee industry and offers recommendations for further reading on Yemen's vibrant history. 0:00 Mocha: A Bustling 17th-18th Century Trade Center0:50 Yemen's Monopoly on Coffee2:46 Nancy Um's Interest in Maritime Trade and Yemen3:40 Yemen's Historical Significance Beyond Recent Decades5:51 What Made Mocha a Prime Trade Hub?7:58 Mocha's Rival: Aden8:11 The History of Coffee as a Drink10:01 Debunking Coffee Origin Myths: The Story of Kaldi and the Goats12:20 Coffee as a Hot Brewed Beverage from Yemen12:32 The Evolution of Coffee as a Commodity and Social Habit13:21 Early Suspicion and Prohibitions Against Coffee14:41 The Global Journey of the Coffee Plant15:57 The Dutch and Coffee Cultivation in Java17:22 Yemen's Shifting Coffee Fortunes18:14 The Ottomans and Yemen's Coffee Cultivation19:06 Ottoman Control of the Red Sea Trade20:37 Diversification of Trade Beyond Coffee21:37 European Influence on Mocha's Popularity22:21 Qishr: Yemen's Unique Coffee Husk Drink (aka Cascara)24:19 Efforts to Rebuild Yemen's Coffee Industry26:01 The Red Sea Trade Route's Enduring Importance29:02 The Indian Ocean: A Space of Exchange and Imagination30:51 Reconsidering Land-Based vs. Water-Based Cultural Identities33:20 Nationalizing Watery Metaphors and Icons35:10 Historical Naming Conventions and Cultural Continuities37:39 Coffee, Tea, and Chocolate: Technologies Reshaping Society40:30 The Coffee House and the Enlightenment42:07 The Decline of Mocha as an Economic Hub43:10 Beneficiaries of Mocha's Decline44:58 Challenge of Contradictory Stories in Historical Narratives47:20 Disproving Coffee Plant Smuggling Myths50:27 Misunderstandings About Yemen's History51:34 Book Recommendations on Yemen53:56 Access to Local Historical Documents in Yemen Nancy Um is Associate Director for Research and Knowledge Creation at the Getty Research Institute. Her research program explores art, architecture, and material culture around the Indian Ocean, the Red Sea, and the Arabian Peninsula, with a focus on trade and cross-cultural exchange in the early modern era. She is also the author of "The Merchant Houses of Mocha: Trade and Architecture in an Indian Ocean Port," and "Shipped but Not Sold: Material Culture and the Social Protocols of Trade during Yemen's Age of Coffee."Connect with Nancy Um

Americans are on edge, and recent polling from the Deseret News and the Hinckley Institute of Politics reveals a growing fear of rising political violence. What’s driving the concern—and how can we get to civility? Greg and Morgan Lyon-Cotti, Associate Director of the Hinckley Institute, break down this polling and where we are as a country.

President Russell M. Nelson...the president of The Church of Jesus Christ of Latter-day Saints...passed away this weekend at 101 years old. Greg is joined by guest host Morgan Lyon-Cotti, Associate Director of the Hinckley Institute of Politics at the University of Utah. The hosts discuss President Nelson's long life of service and faith with KSL TV's Carole Mikita, Sarah Weaver, Editor of the Deseret News, and Aimee Cobabe from the Church News share many highlights on his life and impact.

Welcome to Fertility & Sterility Roundtable! Each month, we will host a discussion with the authors of "Views and Reviews" and "Fertile Battle" articles published in a recent issue of Fertility & Sterility.  This month, we welcome Dr. Lydia Hughes and Dr. Eric Widra to discuss the ethics of egg-sharing, or "split-cycles" for fertility preservation. This is where an egg donor freezes their eggs for their own future use for reduced or no cost in exchange for donating a portion of the cohort. Dr. Hughes is a second-year REI fellow at Northwestern University in Chicago, where she also completed her residency in Obstetrics and Gynecology. She earned her medical degree from the University of Alabama at Birmingham. Dr. Hughes's clinical and academic interests include reproductive ethics, PCOS, and ovarian aging.  Dr. Widra currently serves as Executive Senior Medical officer and Vice President, Development for Shady Grove Fertility and US Fertility, respectively.  He was formerly Chief Medical Officer of SG Fertility, and Associate Director of the Combined Federal Fellowship in Reproductive Endocrinology and Infertility, operated through the NIH, Walter Reed National Military Medical Center and SG Fertility. View Fertility and Sterility at https://www.fertstert.org/    

Two topics are covered in this episode: (1) how parents with lived experience of nonsuicidal self-injury (NSSI) can navigate conversations with their children about their own scarring and wounds, and (2) how parents (with or without lived experience) can navigate conversations about self-injury with their young adult children when they turn 18. Dr. Whitlock is emerita research faculty at Cornell University, a former Associate Director of the Bronfenbrenner Center for Translational Research, and the founder and director of the Self-Injury & Recovery Resources (SIRR) research program, which serves as one of the best and most comprehensive collations of online resources about self-injury: www.selfinjury.bctr.cornell.edu. It is a go-to resource for parents, therapists, friends, family members, schools, other caring adults, the media, and individuals with lived experience of self-injury. Dr. Whitlock is also Senior Advisor for The JED Foundation. To learn more about The JED Foundation, visit https://www.jedfoundation.org/.Below is some of the work referenced in this episode:Whitlock, J., & Lloyd-Richardson, E. E. (2019). Healing self-injury: A compassionate guide for parents and other loved ones. Oxford University Press.Taliaferro, L. A., Jang, S. T., Westers, N. J., Muehlenkamp, J. J., Whitlock, J. L., & McMorris, B. J. (2020). Associations between connections to parents and friends and non-suicidal self-injury among adolescents: The mediating role of developmental assets. Clinical Child Psychology and Psychiatry, 25(2), 359-371.Kibitov, A. A., & Mazo, G. E. (2023). Genetics and epigenetics of nonsuicidal self-injury: A narrative review. Russian Journal of Genetics, 59(12), 1265-1276.Dawkins, J., Hasking, P., & Boyes, M. (2021). Knowledge of parental nonsuicidal self-injury in young people who self-injure: The mediating role of outcome expectancies. Journal of Family Studies, 27(4), 479–490.Want to have a bigger role on the podcast?:Should you or someone you know be interviewed on the podcast? We want to know! Please fill out this Google doc form, and we will be in touch with more details if it's a good fit.Want to hear your question and have it answered on the podcast? Please send an audio clip of your question (60 seconds or less) to @DocWesters on Instagram or Twitter/X, or email us at thepsychologyofselfinjury@gmail.comWant to be involved in research? Send us a message at thepsychologyofselfinjury@gmail.com and we will see if we can match you to an active study.Want to interact with us through comments and polls? You can on Spotify!Follow Dr. Westers on Instagram and Twitter/X (@DocWesters). To join ISSS, visit itriples.org and follow ISSS on Facebook and Twitter/X (@ITripleS).The Psychology of Self-Injury podcast has been rated as one of the "10 Best Self Harm Podcasts" and "20 Best Clinical Psychology Podcasts" by Feedspot  and one of the Top 100 Psychology Podcasts by Goodpods. It has also been featured in Audible's "Best Mental Health Podcasts to Defy Stigma and Begin to Heal."

Today I get to talk with Lakshmi Grama, former Associate Director for Dissemination and Digital Communications at the National Cancer Institute. She shares stories of early days at NCI, bringing everyone to the table, and power dynamics in health information. Communication about clinical trials is a very specialized part of health communication, but stories from […] The post Lakshmi Grama on how people affected by cancer helped shape Cancer.gov's Clinical Trials Information (Part 1) appeared first on Health Communication Partners.

James Case, Associate Director of Revenue Operations at Healthie, shares his non-linear journey into RevOps - from customer service to sales to operations - and the lessons he's learned along the way. He breaks down how frontline experience shaped his empathy for sales teams, the importance of prioritisation and change management, and how Healthy is using AI and automation to remove admin work and let providers focus on care. A candid conversation on resourcefulness, scaling processes, and building systems that last.

Message us!Are you a student planning to become a CPA? An educator shaping tomorrow's accounting leaders? Or a professional navigating a shifting talent landscape?What if the rules just changed and your journey, your curriculum, or your hiring strategy could look completely different?In this episode of Whitley Penn Talks, host Kendall Jones Neukomm is joined by Valerie King, Associate Director of Early Talent at Whitley Penn, and Kirsten Cook, Director of the Lyons School of Accounting at Texas Tech University, to explore the new reality of CPA licensure in Texas following the passage of Senate Bill 262.Building on a previous episode featuring policymakers, this conversation shifts to the educator and employer perspectives. Kirsten shares how SB 262, introducing an alternative pathway to CPA certification, could reshape accounting education, curriculum design, and student decision-making. Valerie offers a boots-on-the-ground view from college campuses, discussing how students are responding and what firms are considering as they adapt to the new reality.Whether you're a student, educator, or employer, this episode offers valuable insights into how Texas is reimagining the path to becoming a CPA and what it means for the future of the profession.Together, they unpack: What SB 262 entails and its implementation timelineThe challenges and opportunities for universities and firmsConcerns around maintaining rigor and CPA exam readinessThe potential long-term impact on the accounting talent pipelineFill out this form to have new episodes sent right to your inbox! Follow Whitley Penn on LinkedIn, Instagram, Facebook, and X for more industry insights and thought leadership!

The international prize in statistics is awarded every two years by a collaboration among five leading international statistics organizations: the American Statistical Association, the Institute of Mathematical Statistics, the International Biometric Society, the International Statistical Institute, and the Royal Statistical Society. The prize recognizes a major achievement by an individual or team in the statistics field, particularly an achievement of powerful and original ideas that have led to practical applications and breakthroughs in other disciplines. The International Prize in Statistics for 2025 was announced recently, and the winner is Grace Wahba. This episode of Stats+Stories is all about celebrating her career with her former students, Finbarr O'Sullivan and Douglas Nychka. Finbarr O'Sullivan is a Senior Post-Doctoral researcher and Associate Director in the National Institute for Cellular Biotechnology at Dublin City University. He has research interests in corneal biology and in limbal stem cell culture techniques for corneal epithelial replacement. In conjunction with collaborators in The Royal Victoria Eye & Ear Hospital, Dublin and the Irish Blood Transfusion Service (IBTS) he has developed the technique of using such cultures to treat corneal-limbal epithelial stem deficiency. This technique received regulatory approval in January 2016 and was used on June 2016 in the clinic for the first time. Douglas Nychka is a statistician who works in applications for the environment. Douglas Nychka is a statistician and data scientist whose areas of research include the theory, computation and application of curve and surface fitting with a focus on geophysical and environmental applications. Currently he is a Professor in the Department of Applied Mathematics and Statistics at the Colorado School of Mines and Senior Scientist Emeritus at the National Center for Atmospheric Research (NCAR), Boulder, Colorado. Before moving to Mines he directed the Institute for Mathematics Applied to Geosciences at NCAR. His current focus in research is the computation of spatial statistics methods for large data sets and the migration of these algorithms into easy to use R packages. He has coauthored more than 100 research articles and with an h-index of 50. He is a Fellow of the American Statistical Association, Fellow of the Institute for Mathematical Statistics and a recipient of the Jerry Sacks Award for interdisciplinary research.

JD Garza is the Associate Director of the California Area Health Education Center (AHEC), hosted at UCSF Fresno, and a board member of the National AHEC Organization. His career centers on partnering with community organizations to serve medically underserved communities. In this episode, JD breaks down how AHEC recruits, trains, and retains health professionals for rural and underserved areas—at scale. We get into AHEC Scholars (a two-year, interdisciplinary track with community projects), clinical placements across community health centers, and why elevating CHWs, MAs, and CNAs is key. He also shares a standout youth diabetes coaching partnership, outcomes to date, and a practical burnout-prevention curriculum (“Healing from the Heart”) co-built with Hennepin Healthcare.What You'll Learn From This Episode:Introduction to JD Garza and AHEC Overview of California AHEC California AHEC Centers and Partnerships AHEC Programs and Initiatives AHEC Scholars Program Burnout Prevention and Resiliency Program Future Plans and ConclusionResourcesCalifornia Area Health Education Center (UCSF Fresno) National AHEC Organization HRSA Area Health Education Centers (AHEC) Program Hennepin Healthcare — Institute for Professional Worklife (burnout resources)Stanford Youth Diabetes Coaching Program The CSRHA has been a go-to resource for rural healthcare and community leaders since 1995. The CSRHA brings an accumulation of actionable insights to the next generation of rural healthcare leaders. For more behind the scenes of this podcast follow @CSRHApodcast on Twitter or @csrha.advocate on Facebook.If you enjoy This Is Rural Health, we could use your support! Please consider leaving a 5-star rating and review, and share it with someone who needs to hear this!Learn more about the CSRHA at csrha.org.

Stand Up is a daily podcast that I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous souls Tim Wise Link Tree Tim Wise, whom scholar and philosopher Cornel West calls, “A vanilla brother in the tradition of (abolitionist) John Brown,” is among the nation's most prominent antiracist essayists and educators. He has spent the past 25 years speaking to audiences in all 50 states, on over 1000 college and high school campuses, at hundreds of professional and academic conferences, and to community groups across the nation. He has also lectured internationally in Canada and Bermuda, and has trained corporate, government, law enforcement and medical industry professionals on methods for dismantling racism in their institutions. Wise's antiracism work traces back to his days as a college activist in the 1980s, fighting for divestment from (and economic sanctions against) apartheid South Africa. After graduation, he threw himself into social justice efforts full-time, as a Youth Coordinator and Associate Director of the Louisiana Coalition Against Racism and Nazism: the largest of the many groups organized in the early 1990s to defeat the political candidacies of white supremacist and former Ku Klux Klan leader David Duke. From there, he became a community organizer in New Orleans' public housing, and a policy analyst for a children's advocacy group focused on combatting poverty and economic inequity. He has served as an adjunct professor at the Smith College School of Social Work, in Northampton, MA., and from 1999-2003 was an advisor to the Fisk University Race Relations Institute in Nashville, TN. Join us Monday's and Thursday's at 8EST for our Bi Weekly Happy Hour Hangout's !  Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on YouTube  Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Follow and Support Pete Coe Buy Ava's Art  Hire DJ Monzyk to build your website or help you with Marketing Gift a Subscription https://www.patreon.com/PeteDominick/gift

Dr. Patricia Tan serves as Medical Director for Rusk Pediatrics Rehabilitation. Her Certification is from the American Board of Physical Medicine & Rehabilitation. She has been selected as a Fellow by the following organizations: American Academy of Physical Medicine and Rehabilitation; American Academy of Pediatrics; American Academy of Cerebral Palsy and Developmental Medicine; and the Association of Academic Physiatrists. Her medical degree is from the University of Santo Tomas in Manila, Philippines. Dr. Megan Conklin is Associate Director of Rusk Pediatric Therapy Services at NYU Langone. She works collaboratively with an interdisciplinary team across the spectrum of pediatric diagnoses from birth through the transition into adulthood. She has a Doctor of Physical Therapy degree, 20 years of clinical experience at NYU; and is certified as a clinical specialist in pediatric physical therapy by the American Board of Physical Therapy Specialties of the American Physical Therapy Association. Part 1 The discussion included the following topics: kinds of health problems and conditions treated; age range of patients; clinical guidelines and evidence-based treatment protocols used; holistic approaches to treatment; collaboration with families of patients; and composition of the health care team

In 2025, Savills Impacts thought leadership programme is themed around Adapt, because, now more than ever, it is time for the real estate sector to adapt if it is to thrive. In episode one of our two-part series, we look at how recent changes in the flows of wealth and talent are impacting individuals and real estate occupiers in different regions.  Rachael Kennerley, Director of Research and Advisory for the Middle East; Arvind Nandan, Managing Director of Research and Consultancy for India and Kelcie Sellers, Associate Director of Savills World Research join Guy Ruddle to explore how likely these trends are to become permanent, the new hotspots for living and working, and how occupiers are adapting their strategies to talent shortages and advances in technology. For more insights and content unpacking the future of global real estate, explore Impacts content here. Part 2, examining some of the largest macroeconomic and geopolitical trends around investment, technology and climate change, will be published shortly.

Welcome to the Water Quality Association Podcast. https://wqa.org. In this episode, we'll hear from WQA President Mike Mitchell at the recent WQA Mid-Year Leadership Conference. WQA's Associate Director of Marketing & Communications handles the interview. Mike shares insights from the Mid-Year Leadership Conference and reflects on the first half of his presidency. A key theme of his term is influence—building trust, listening first, and creating meaningful connections to shape conversations across the water treatment industry. From connecting with regional associations like the Texas and Eastern WQAs, to meeting directly with lawmakers in Washington, Mike highlights the importance of grassroots engagement and national advocacy. This episode is sponsored by Corro-Protec powered anode rods for water heaters. With a 20-year warranty, Corro-Protec eliminates sulfur smell in hot water within 24 hours and prevents tank corrosion without any maintenance. A must-have for homes with softened water. Enjoy hassle-free hot water with Corro-Protec! Visit https://corroprotec.com/wqa/ to learn more. Learn more about becoming a WQA member at https://wqa.org/membership.

In this episode, we step inside the NHS to explore how the Generation Study is brought to life - from posters in waiting rooms to midwife training. We follow the journey of parents joining the study at the very start of their baby's life, and hear from those making it happen on the ground.  Our guests reflect on the teamwork between families and hospitals, the importance of informed consent, and the powerful insights this study could unlock for the future of care and research.  Our host Jenna Cusworth-Bolger, Senior Service Designer at Genomics England, is joined by:  Tracie Miles, Associate Director of Nursing and Midwifery at the South West Genomic Medicine Service Alliance, and Co-Investigator for the Generation Study at St Michael's Hospital in Bristol Rachel Peck, parent participant in the Generation Study and mum to Amber If you enjoyed today's conversation, please like and share wherever you listen to your podcasts.  For more on the Generation Study, explore:  Podcast: How has design research shaped the Generation Study  Podcast: What can we learn from the Generation Study  Podcast: What do parents want to know about the Generation Study  Blog: Genomics 101 - What is the Generation Study  Generation Study official website   “I think from a parent's point of view I guess that's the hardest thing to consent for, in terms of you having to make a decision on behalf of your unborn child. But I think why we thought that was worthwhile was that could potentially benefit Amber personally herself, or if not, there's a potential it could benefit other children.” You can download the transcript, or read it below. Jenna: Hi, and welcome to Behind the Genes.   Rachel: I think if whole genome sequencing can help families get answers earlier, then from a parent perspective I think anything that reduces a long and potentially stressful journey to a diagnosis is really valuable. If a disease is picked up earlier and treatment can start sooner, then that could make a real difference to a child or even Amber's health and development. Jenna: My name is Jenna Cusworth-Bolger and today I have the great pleasure to be your host. I'm a senior service designer at Genomics England specifically working with the hospitals involved in delivering the Generation Study. In March 2023 we started with our very first hospital, St. Michael's in Bristol. I am today joined by Tracie Miles who I had the utter pleasure of working closely with when they were setting up. And we also have Rachel Peck, one of the mums who joined the study in Bristol. Regular listeners to this podcast may already be familiar with the Generation Study but for those who are not, the Generation Study is running in England and aims to sequence the genomes of 100,000 newborn babies from a cord blood sample taken at birth. The families consented to take part will have their babies screened for over 200 rare genetic conditions most of which are not normally tested for at birth. We expect only 1% of these babies to receive a condition suspected result, but for those 1,000 families that result could be utterly life changing as it could mean early treatment or support for that condition. Would you like to introduce yourselves and tell us what it means to you to have been that first hospital open in this landmark study. Tracie, I'll come to you first.  Tracie: Hi Jenna, lovely to be with you all this morning. And for those who are listening it is early in the morning, we get up early in the morning because we never know when these babies are going to be born on the Generation Study and we have to be ready for them. So, my name is Tracie, I am the Co-Investigator with the wonderful Andrew Mumford, and we work together with a huge team bringing this study to life in Bristol. I am also the Associate Director of Nursing and Midwifery at the South West Genomic Medicine Service Alliance. Jenna: Thanks Tracie. We're also joined today by Rachel. Would you like to introduce yourself and your baby, and tell me when you found out about the Generation Study?  Rachel: Hi, thank you for inviting me. My name's Rachel, I'm based in Bristol. My baby is Amber; she was born four months ago in St. Michael's hospital in Bristol. I first heard about the Generation Study when I was going to one of my antenatal appointments and saw some of the posters in the waiting room. Amber is napping at the moment, so hopefully she'll stay asleep for long enough for the recording. Jenna: Well done, that's the perfect mum skill to get a baby to nap whilst you're busy doing something online. So, Rachel, you said you heard about the study from a poster. When you first saw that poster, what were your initial thoughts? Rachel: I thought it was really interesting, I haven't come across anything like that before and I thought the ability to screen my unborn baby at the time's whole genome sounded really appealing.  Jenna: Fantastic. So, what happened after the poster?  Rachel: If I remember correctly, I scanned the QR code on the poster which took me to the website. I filled out a few simple questions online and then I was contacted by one of the research team where I arranged a formal consent conversation. That was done by Zoom I think in the evening because I've already got a toddler at home so post bedtime works best for me. So, we had about a forty-minute conversation on the phone where I could ask all the questions that I needed to ask and if I was happy which I was. I then gave my consent and then I believe my maternity records were kind of highlighted to say that I signed up for the Generation Study and that when my baby was born then a sample was going to be taken, and I would be given the results in due course. Jenna: And did all that go smoothly, that you're aware of? Rachel: Yeah, as far as I'm aware. It was genuinely really simple to do. After that initial consultation where I signed the consent form there wasn't any follow-up appointments so the next thing I knew, I think it was just chance, but one of the research nurses actually came down to see me on the day which was really nice. Just to say, ‘Oh, just to let you know that the team are aware.' And then, other than that, the next thing I knew was getting the results through by post. Jenna: Sure. So, behind the scenes your baby's blood was collected from the umbilical cord, that would have been registered, packaged, sent off and went on a whole journey for you to ultimately get your result. It all sounds very simple, but I think we're going to dig into a lot of the mechanisms that kind of went behind the scenes to make something that seems simple come to life. Tracie, we met in the summer of 2023 I believe. I came to St. Michaels with a suitcase full of our materials which we had started to bring to life, including that poster. We've sat together and we were trying to figure out exactly how this was going to come to life in our very first hospital and how, what Rachel described, was actually going to become real. Tracie, can you tell me what you remember about those conversations and the thinking that you did as a team ahead of getting that green light to go ahead and start recruiting?  Tracie: Listeners, just to let you know that Rachel hasn't been primed to say that it was a seamless journey from delivery to getting results. I'm delighted to hear that it was. And I think the reason that we've achieved that in Bristol and across England now with the other teams that Jenna and the team have helped roll out, is teamwork. And part of our team is our mum, in this case Rachel. If you hear me or Jenna describing our mums as "Mia", that's the name, the significant name or the identifier we give for our participant. So, yeah, Jenna, I think the thing was it was about those first conversations. It was about teamwork and who shall we involve? We involved everybody didn't we, Jenna? So, I know that the team, by the time they came to us they'd already been planning for two years. So, in fact what came to us in Bristol was a wealth of work and information, and two years of behind the scenes of the team working. We involved every midwife. Now a midwife is a cover all term.  We involve community midwives, research midwives, antenatal midwives, post-natal midwives. They all do different things for the mum pathway. Not forgetting dad as well, he is involved in all of this and Rachel I'm sure will testify later to the fact that when she was offered the consent, her partner was offered to come along too. UHBW, that's United Hospital Bristol and Western, that our maternity hospital as part of, have got a fantastic R&D department and they were on straightaway with the rule book checking that we knew what we were doing. So, for those of you that aren't in the medical world, that's making sure we've got the right governance, that we're doing things by the rule book. Andrew went out and spoke to lots of different clinicians that would be involved in the pathway after the results were back, for those babies where we found a condition suspected. So, essentially Jenna, I think the list that was fairly long, grew longer and longer. Jenna: I think that was something that I was really struck by when I came back and visited you repeatedly after that. You were particularly good at getting some of those staff members that you might not even think about involved in the study, like the receptionist on your sonography department who you had recruited to make sure that they gave out the leaflet and the participant information sheet to all the mums coming in for their twenty-week scans etc. All that thinking was really valuable and something that I've passed on and taken out on my trips to other hospitals along the way. We heard from Rachel that she heard about this study from the poster. Now that you've been going for just over a year, what are all the different ways that people hear about the study, is it just the poster? Tracie: No, it's not just the poster. So, essentially when we first opened, we had lots of material. We had banners, we had posters. A short leaflet that you might often pick up at the GP, a little one that you can unfold into three pieces, and then a bigger patient information leaflet which actually described the whole study and also signposted the mums and dads to go and have a look on the website to hear more about it. What we did was we literally walked the mum's journey as she came into the hospital through antenatal and placed those posters and leaflets in the places where we knew she would see them. Now we had to be very careful about that as well because we couldn't just distribute them everywhere, we wanted to make sure that mum was getting sight of them, or mum and dad if they were coming together, at a place where their pregnancy was in hopefully, a safe position. So, that's around about 20 weeks onwards.   We didn't want to be giving that information out in the early days of pregnancy when actually mum and dad are getting flooded with lots of information, but we wanted them to feel secure in their pregnancy and for us to feel clinically secure. That worked really well and really effectively, but there's nothing like people pairing. So, in fact getting our ultra sonographers. So, for those of you that have been through pregnancy will remember at around about twenty weeks you have a scan, it's often called a dating scan or an anomaly scan, and we would get our receptionist to physically hand out a leaflet then. What we have evolved over the last year working with the team from Genomics England to make sure that we keep the wording right so that we can share with all the other sites across England, because it's good to have consistency. And also, as this evolves if this becomes standard of care, if this proves that actually this is useful for future-proofing for all of us in the public, if this study becomes something in real clinical terms, we've actually started sending out what we call, a signposting email. So, this is an email that goes to all of our prospective parents at 20 weeks plus, once we've checked that the pregnancy is safe and healthy. That has absolutely paid dividend and actually plays into the NHS future promise of analogue to digital to using those quick smart ways of working to reach our families. So, that has created a huge influx of recruits for us, Jenna.  Jenna: That's really interesting. We've sort of observed that same sort of thing. As we go through the hospitals now there's kind of three main ways that people are finding out the study. We call it like the passive way. So, that's what Rachel did which is the posters, the banners, but that doesn't work for everyone. In hospitals poster blindness is real. And also, you're coming for your twenty-week scan, you've got other things on your mind. You're not really looking around wanting to pick up leaflets and things and obviously we've also got to think about our non-English speakers. Or even an English speaker who sees the poster, but their literacy isn't very high, or their health literacy isn't very high. So, reading a message that says something about genomics and testing, it can be quite overwhelming for people and not something that they would respond to.  So, then we're signposting as our other kind of keyway and that's trying to get exactly what Tracie described, all the different staff involved. Who could be physically putting this leaflet in somebody's hand? Who could be mentioning it albeit briefly, just, you know, this is something you might like to consider. Rachel, I want to ask you what Tracie was describing there about the message kind of being better to be given later in pregnancy or after that 20-week scan point, because of all that information overload you get earlier in your pregnancy. Does that resonate with you?  Rachel: Yeah, I think that sounds about right. For lots of people when there's so much uncertainty in early pregnancy and I think some people are quite almost superstitious and don't want to sign up for things that potentially might not happen. So, I think from a personal perspective and from other friends who haven't been quite as fortunate, I think actually waiting until a little bit later when you've got a little bit more headspace and mental capacity for that sounds about right. I think there's too many things early on. It sounds like you're aiming at the right spot. Jenna: Absolutely. I think one of the other interesting aspects of all of this is the fact that Amber's cord blood was taken on the day that Amber was born, and I'm interested to understand a little bit about how that baton was passed from the moment that you consented, Rachel, to make sure that that sample was taken. I know it sounds like Rachel; you were in hospital at a point that the staff were there so they actually popped down to your bedside to see you but that doesn't always happen. Our teams don't work 24/7 and babies do get born at 2:00 a.m. over a bank holiday weekend. But Tracie, how do you make sure that that kind of message is passed through at St. Michaels, and what's worked well and what have the challenges been?  Tracie: So, a bit like how did we get the message through, is there one way? And the answer is no. There are posters, there are emails, etc. What we do do is first and foremost we encourage our mum, like Rachel here, and the dad, it might be two mums coming in together, to advocate for themselves. To say, ‘I'm on the Generation Study.' We don't expect that to be the only signal however because if a mum is coming in in full labour having done that a couple of times myself, I might forget. Now Genomics England have made some great bag tags, some stickers, all sorts of different visual identifiers that some hospitals around England are using, some aren't. We in fact actually don't get our mums to carry them, that may change. There are lots of different ways of doing it and every hospital maternity unit will find their fit. So, visual clues that mum and dad, or mum and mum, advocating for themselves as they come in, but also making sure that we have spoken with the delivery suite midwives and the theatre midwives.   Because in our hospital, which it seems to be the same sort of ratio around the country, sometimes up to about 40% of deliveries are done in theatre. So, we need to make sure we talk to our theatre staff and the people there as much as our central delivery or labour ward, for listeners who aren't familiar with the terms. So, we make sure that we went and walked the floor in the delivery labour ward and theatre on a regular basis. So, the task for us was to make sure that our midwives, all 200 of them know that if a mum is in the Generation Study and coming in for delivery, that they know that she's on the study. So, ways we do that is research midwives are an absolute ally, they do walk the floor. They do pop down to delivery suite and they do alert the team that there is a potential that a mum might be coming in that week with a planned Caesarean section, that's one easy. That actually can be an email. But we still do that by word of mouth, or they have a big board up in the delivery suite, which I gather is quite often the way across a lot of the country. Also, really, really key and this once again fits with our NHS plans, analogue to digital. The majority of our sites now are taking on electronic records. So, we put a key flag on the electronic record to say that this mum is on a research study. Staff are used to that because it's not the only research study that is happening. Now it doesn't have to just be an electronic note, it can be done on the retro paper notes as well. So, for those of you that have got paper notes or if we've got mums who are holding paper notes, fear not, there is an area on the notes where we can put that too. So, it's basically anywhere where we know the delivery midwife has sight of the babies' notes we will put a sticker, we will say something. So, it's one size doesn't fit all. Jenna: Yeah, what you've described there is just so lovely and so true about it's got to be belt and braces. The research team, the study team and the hospital might be a small number of people working Monday to Friday. Your people you completely rely on are those huge numbers of delivery midwives that need to have that message transmitted to them potentially over a 20 week timespan from the time the consent has happened to that day that that baby is born. So, what was really key as my role as service designer was going to the sites. I'm still doing this to this day, onboarding new sites all the time. We go and we speak to the sites, help them envisage how they might deliver this, how it's actually going to work. What's the nitty-gritty of all that mechanism that's going to happen but making sure that what they really understand is, what's the outcome? What do we want to happen? We want as many babies as possible to have those cord bloods taken and not missed. How you actually send that message whether it's through a paper note, a sticker on a paper note, giving a pack to the family to bring in so they've got something physical to hand over to their delivery midwife as a physical memento. Magnets that are put on the handover boards, or any or all of these things, in lots of ways the hospitals that have still got paper notes actually find it easier because that can staple a bag with the bottle that we use for our cord blood samples and this mum is part of the Generation Study to the front of the notes. It's more obvious than it would be as a digital flag. Tracie: I totally agree with that, it's all about that visual cue that we were talking about earlier. We actually fund a midwifery support worker, her name's Lauren. Hello Lauren, if you're listening. And what Lauren does is actually she makes sure that in all the rooms where women deliver that there are little set bags with all the equipment needed to take that cord blood. She also came up with a brilliant idea and again, a visual clue and Genomics England help us to design it, a poster. We would put on the outside of the door of mum and dad when they said they were on the study. So, if you've got a changeover of midwives then those midwives know that they're going into a room to support and deliver a mum that's got a baby on the study. Jenna: And I think that's something that's really key is what you said there about Lauren and her bright idea to create that poster and things like that, and that's been really key to how we've worked from Genomics England as a kind of service design kind of wrapper if you like around all of these hospitals. I have taken on the role of chief pollinator, so I've flown from hospital to hospital taking all the best ideas. So, Lauren's idea of the poster, I came along and I took a photograph of that poster. That poster is in a slide and that slide gets shown when I go and do onboarding and training sessions with future hospitals. Bristol were really key because as our first site and as the first early days check in we did, the photographs I took at your hospital at Birmingham Women's and at the Rosie in Cambridge which were the first three hospitals, you still to this day make up a large percentage of what we show because you were the first to have all those great ideas and we share those out. But we don't go round all the other hospitals, and we have found new ideas all the time and they are put together in our service design manual which is all available for all the sites. Something that St. Michael's can refer back to to see what new things they could be thinking about. But basically, raising up the best and allowing hospitals to borrow from each other. Before we just move on from how it all works, I just want to ask Rachel, did you notice any of that or were you very busy having a baby? And did you remember to kind of advocate to yourself and mention the study? Rachel: I did remember to advocate for myself, also it was one of the jobs that I allocated to my husband as well as a, well, if I forget which is likely, can you make sure that you mention to them. I had a caesarean section. For other people who have had caesarean sections, there's quite a lot of waiting round time. So, when we were in the theatre getting ready, having a chat with the anaesthetist it was a nice opportunity to be able to take my mind off the impending surgical procedure and just mention about the Generation Study. But incidentally, they knew about it anyway. I think I remember seeing some kind of sticker or maybe the blood tubes or something on my theatre records. But see them taking the sample, I wasn't aware, I had other things on my mind at that point. Jenna: Absolutely. You were cuddling Amber for the first time probably. One of the things that you touched on Tracie, was you had to go round all of your delivery suite midwives and make sure they all knew how much blood to take, what tube to put it in. The fact that they had to invert it 10 times, put it in a particular fridge so that you knew where to find it. All of those are really important training messages that you had to pass on. But for you to be able to pass them on, we had to train you in the first place. So, my memory was that we came down to you one cold December day and spent a whole day with you down at St. Michaels trying our best to train you as seamlessly as we could. My memory of that day is it wasn't terribly slick because it was our first and we're always learning. I'd like to think we've got it a lot more slick now, but what do you remember about that day? And just in general kind of learning what you needed to do on the study and what kind of worked well for you, and what worked less well? Tracie: I do remember that day, it was very cold. I think what's changed Jenna is on that December day the whole team felt that they were having to take on the whole of the journey. They now as the work has developed, realise and learn the part of the journey that they need to be involved in and don't have to be concerned about the rest of the journey. Jenna: I learnt an awful lot and I think it's really true that it's really important that people who are taking the samples, they just need to know their role. But they do need to know a little bit about what the study is, why it's worthwhile, why this mum has signed up and what value it's going to bring to that family. I think the other thing that we learnt when we came to your training as well was in the same way that we went a bit too deep for some people in their role, we didn't go deep enough for your team that were actually going to be doing these consent conversations. At that, at end of that training day, you still felt trepidatious about doing those conversations and so we really took that on board and then developed our informed choice cards which are like scenario cards that allow teams to kind of practice, rehearse and think through how they're going to answer those common questions. And we've taken those into a session that allows people who are just doing the consent conversation to go even deeper, so we do that online in a webinar now which we run monthly and that allows any new members of staff to go that little bit deeper in terms of what is this consent conversation? What is it that I need to get people to understand and be fully informed about before they come into this study? A key objective of the Generation Study which after all is a research study, is to understand if the NHS and families would benefit if screening for conditions via whole genome sequencing was something that became part of NHS standard care. Rachel, can I ask you as a mum, is that something that you've reflected on at all and how would you feel about it?  Rachel: Yeah, I've thought about quite a bit. I think if whole genome sequencing can help families get answers earlier then from a parent perspective, I think anything that reduces a long and potentially stressful journey to a diagnosis is really valuable. If a disease is picked up earlier and treatment can start sooner, then that could make a real difference to a child or even Amber's health and development. So, I think that would be potentially very advantageous. I guess in a resource limited NHS that we have, there are, you know, clear challenges in rolling out whole genome sequencing for everyone. But I'm guessing that the Generation Study will provide the evidence to help understand if this is feasible or worthwhile. And clearly the Generation Study needs to show that the screening of these 200 or so conditions is as good as the existing screening that already exists. From a parent perspective, if it's shown to be equally as good at doing that, plus all these other disorders then it seems like a win-win.  I think for me the main advantage and the main reason why I was keen to enter for Amber was if she were at risk of getting one of these rare disorders then there's an advantage to picking that up earlier for her. Because I'm aware that lots of people if they have a rare disorder, it can take a long time to get to that diagnosis and that can be really stressful for you as the parent but also for the child. Anything I think to minimise their suffering is worthwhile. So, it sounds fantastic, if it works. Jenna: Absolutely and I think that's what's really nice about being involved in something like this is that the study itself is set out to find out those things. It's not set out to find out how we could do whole genome sequencing in the NHS, it's whether we should. As part of the study, you also consented to have Amber's data go through into the National Genomic Research Library which leads us to one of the secondary objectives of the Generation Study which is to understand the implications of keeping a baby's genomic data over their childhood, or even over their lifetime. Amber will be contacted when she is 16 by Genomics England to find out whether she herself is happy for her data to be kept. But keeping that data for that length of time offers up opportunities for further screening for other conditions later in Amber's life. Or using that data with your consent of course, to do further research into genes and health. And so over the next few years you may be contacted by Genomics England to invite you to take part in future studies. And, I was just wondering about how much you have been told about the potential for that and again, how you feel about that kind of aspect of being part of this study. Rachel: Yeah, that was definitely discussed quite a lot in the consent conversation that I had with Siobhan, and we were told that Amber's data would be stored long term and that there might be future opportunities for the team to kind of get in touch or do additional testing. And I think from a parent's point of view I guess that's the hardest thing to consent for in terms of you having to make a decision on behalf of your unborn child. But I think why we thought that was worthwhile was that could potentially benefit Amber personally herself, or if not, there's a potential it could benefit other children. So, I think that whole kind of for the greater good, that kind of prevailed. And I think the other, not concern as it were, but other thing we wanted to discuss with that consent was the security of that data. And certainly, when I was discussing it with my husband that was his kind of main point to kind of clarify, if the data is being stored long term and if that was safe. And in terms of the safety, thinking about could future employers or can insurance companies, you know, get hold of that data? As a parent, the last thing you want to do is accidentally prevent your daughter from getting a job that she wants to get. But it was all explained that that wouldn't happen, but I think that was something that was us for us personally important to clarify. Jenna: I think that's really where that depth of the consent conversation is so key and why we do that sort of additional training to allow staff who may be very used to doing research and doing research consent, but never before have done a genomic consent where it's about keeping genomic data and the implications of keeping it for that really long time. What else do you remember about that consent conversation, Rachel? Is there anything else that kind of stands out that you had to sort of really dig into with Siobhan on that day?  Rachel: I'm just trying to think back because it was a little while ago. The main kind of points that I want to discuss was the security of the data and then what would happen if for whatever reason the umbilical cord blood sample wasn't taken and if that meant that we could still be part of the study or not. It was explained that yes, there is a way, they would do an initial heel prick blood sample. But that was reassuring to know that if for whatever reason if there was some kind of emergency and it didn't happen the way we wanted. So, I think that was the other kind of practical thing that was discussed.  Jenna: It sounds like Siobhan sort of had by that point all of the answers at her fingertips, but that kind of links back I guess to how important it is for all the training and all of the materials, because quite a lot of the answers to those questions are in the participant information sheet. Quite a few of them are covered in the participant video which is a sort of a four-minute-long video, it's meant to make the understanding a little bit more accessible. But it's not relying on one route of information, it's the conversation and that face to face you have with someone. It's the written information and it's those videos and other materials. So, we need to go as far as we can to kind of get the word out. One of the limitations that we had, certainly back in the day when we just had St. Michael's and a couple of other hospitals on board was that trying to get the word out about the study widely was also going to disappoint quite a lot of people who weren't able to take part because their hospital wasn't in it. We've talked a lot about this consent conversation, and I think something that's really important, underpinning for the whole study is the ethics that's been involved and all the work that's been done around that area. As the study is free and optional and taking part involves a commitment from families to have babies' data held for at least 16 years, the consent conversation and getting that right is so vital. We touched upon this in a previous episode with my colleague Mathilde Leblond where we talked about all the design research that our team did in the build up to launching this study, so that we could really deeply understand what families wanted and needed as part of their experience. So, Tracie, we've heard from Rachel the things that she was concerned around, but what were your reflections as a team in St. Michaels around the ethical aspects of the study? And what has been particularly tough about that in relation to you guys in Bristol? Tracie: I would say informed consent is something that we all take as healthcare professionals, and we all hold dearly the governance. So, I was mentioning earlier that actually consent may not be a one-off situation. So, for example, Rachel had forty minutes with Siobhan. That was the conversation that she had where Rachel felt that she was enabled and informed enough to take consent, and Siobhan listening to her having that conversation with Rachel felt that that was appropriate at the time. So, consent was achieved between the two of them. Now, that wasn't the only part of Rachel's consent is Rachel was telling us there's the patient information leaflet that she read, so that's also part of the informed consent. And we have to be sure that our mums and the other parent of the baby have read that information. And one of the things that I was very worried especially about at the beginning was it's a superb information leaflet, it's quite long, it needs to be. It signposts the parents of the unborn baby to a website which is fantastic. Do they all look at it? Not always. Would I? Probably not. So, there's no criticism of the parents here. So, one of the things that I was really concerned about from the genomics perspective of this and the data protection because this is not a one-off, this is a longitudinal study. Amber when she's 16 years old will decide whether or not she wants to continue, so it's not a one-off moment that her lovely mum and dad have consented her for. There's a lot that's been consented for. All great and all appropriate and all future-proofing for future Ambers. But my concern was actually, are we getting that information across to all the mums and dads as they sign up? So, it was really important that when we were training our midwives and our genomic practitioners, those that were consenting, to make sure that they were really cognisant of the enormity of the wealth of science we were signing our parents and their babies' futures up to. Jenna: Indeed, and very well said and I think you touched on something that is really close to our hearts as well that we've thought a lot about but still continue to do work to get right, which is the patient information leaflet if you have the health literacy and written language literacy to be able to sit and read a 16-page document, great, but not everybody does. As I've gone place to place and hospital to hospital, I'm always struck by the different communities that surround different hospitals and the different challenges that they might have. So, if you compare somewhere like Royal London which is in the heart of Whitechapel, I think around 40% of their birthing parents there are first generation Bengali women who have little to no English. Also, whose health literacy is quite low as well. So, engaging them takes a very different approach to an approach you might take elsewhere. So, it's definitely not a one size fits all. Tracie, how have you adapted some of your approaches to your local communities in Bristol? Tracie: So, we have a fairly diverse population, not as diverse as the Whitechapel example that you gave, but in fact we were aware, a bit like the team in London that we have a population of Somali potential birthing parents. What we've done is we've worked with community leaders and elders from the Somali population to develop a day, or it might be a couple of mornings, for us to talk about and workshop to explain about the study. So, we have all of the information. We have the translations that have been done by Genomics England. And hat we are doing is we are working with the community elders for them to tell us the right fit. Should it be a whole day? Probably not. Should it be a coffee morning or a tea morning? Probably. Should it be where we get a guest speaker in? That was their idea. What is the key condition suspected, one of those 200 conditions that the study is looking at that is prevalent in that community? Let's ask the community elders what they think, and we'll do what we're told. So, it's been fabulous actually doing that. Jenna: It's really, really great to hear about that. I think we've got little pockets of work like that popping up all over the country now which is really exciting to start seeing. I think at first, we were very much about getting the study up running and out there. And now we're starting to make sure we get that reach and we get that equity, and the opportunity for all pregnant people to decide whether this is right or wrong for their family. It's about informed choice and you can't make an informed choice whether that's an informed yes or an informed no if you don't have the information. We are proud that we go further than most research studies in terms of our accessibility, in terms of translations and we know that not English speaking is not the only barrier to access, there's lots of cultural barriers as well. But with the translated materials we support 10 languages as far as our professionally translated participant information leaflet. I was also really pleased when I found out at first that our website team had built the website in such a way that it worked not only with screen readers. So, somebody with a visual impairment could ‘read', in inverted commas, the website but that also it translates via Google into the 160 languages that Google support, which we know Google translations aren't perfect but they're better than nothing. And going back to what Tracie sort of said, the website doesn't have to do everything, it's about a conversation at the end of the day. It's a consent conversation that can be supported by a professional interpreter but it's about getting that initial message out there so they even get as far as having that conversation with an interpreter. We heard from Rachel around her reflections for the future, Tracie, about the study potentially becoming NHS standard care and about that potential of us having Amber and 99,999 other babies' data in the National Genomic Research Library and the potential that gives us for further research. Or for potentially re-screening those children as they grow up. When you look to the future and think about the Generation Study and what it might pave the way for, what are your hopes or perhaps fears? Tracie: So, my belief working in the genomics field is genomics is everybody's business. So, it's the 3 of us talking today, we're all very keen about genomics but there is a fear around genomics. Actually, I feel that this landmark study is absolutely fantastic. It makes genomics everybody's business. And it actually helps the whole healthcare community looking after these parents and the unborn babies as they go through the journey learn about the positivity of genomics. I think this landmark study is an absolutely win-win. It speaks to the whole family. Jenna: Thank you, Tracie. I'm also particularly excited about what the future could hold. I think as the service designer that's been working so closely with the hospitals, I'm really excited around what we've learned through this study in terms of reaching families and getting genomic information and options out to them. As you say, it is everybody. I continue to enjoy meeting new hospitals and seeing their kind of innovative take on that and kind of pollinating that back to other trusts so that we can reach as many families as possible and get that equity of access for everybody. I'm also particularly excited that we're moving into a phase where we're going to be learning more from the parents themselves that are taking part.  So, I think we'll wrap up there. Thank you to our guests Rachel, Tracie for joining me today as we discuss the rollout and impact of the Generation Study at St. Michael's Hospital in Bristol. If you'd like to hear more about this, please subscribe to Behind the Genes on your favourite podcast app. Thank you for listening. I've been your host Jenna Cusworth-Bolger. This podcast was edited by Bill Griffin at Ventoux Digital and produced by Deanna Barac.

Two leading voices in the fight for environmental and human rights justice are Steven Donziger and Paul Paz y Miño. Steven Donziger is an attorney and activist known for his decades-long legal battle against Chevron on behalf of Indigenous peoples and rural communities in the Ecuadorian Amazon. His work has drawn international attention to issues of corporate accountability, climate justice, and the criminalization of human rights defenders. Paul Paz y Miño is the Associate Director of Amazon Watch, a nonprofit organization dedicated to protecting the rainforest and advancing the rights of Indigenous peoples in the Amazon. For over 20 years, he has worked to build international solidarity, expose corporate abuses, and amplify the voices of frontline communities resisting environmental destruction. Together, Donziger and Paz y Miño discuss their work for environmental justice, the ongoing struggles of affected communities, and the broader fight to hold corporations accountable for human rights and ecological harms.See omnystudio.com/listener for privacy information.

The guest host for today's show is Brad Bannon. Brad runs Bannon Communications Research, a polling, message development and media firm which helps labor unions, progressive issue groups and Democratic candidates win public affairs and political campaigns. His show, 'Deadline D.C. with Brad Bannon,' airs every Monday from 3-4pm ET. Brad is first joined by Kate Ackley, a Senior Reporter for Bloomberg Government. The two examine the impending government shutdown, which is set to happen October 1st.  Democrats seem less eager to bail out Republicans than they did at the beginning of the current Trump administration, drawing the line at new massive healthcare cuts which would drive up premiums 10-20% for folks with Affordable Care Act health plans. Then, Brad is joined by Dr. Bob Bollinger is the Raj and Kamla Gupta Professor of Infectious Diseases at the Johns Hopkins University School of Medicine. They examine the chaos caused at the CDC by RFK Jr. and the Trump administration, and the potentially dangerous new restrictions on who can now receive vaccines.   Dr. Bollinger holds joint appointments in International Health at the Johns Hopkins Bloomberg School of Public Health, and in Community Public Health at the JH School of Nursing. He has more than 45 years of experience in international public health, clinical research, and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic resistant infections, COVID-19 and other emerging diseases.  Dr. Bollinger is also Associate Director of the Center for Clinical Global Health Education (CCGHE). Their website is main.ccghe.net.  Brad writes a political column every Sunday for 'The Hill.' He's on the National Journal's panel of political insiders and is a national political analyst for WGN TV and Radio in Chicago and KNX Radio in Los Angeles. You can read Brad's columns at www.MuckRack.com/Brad-Bannon. His handle on BlueSky is @bradbannon.bsky.social.  

Originally released May 14, 2024. New Kindred episodes will drop starting in October 2025.In this week's conversation, we are speaking with William Housty, Associate Director of the Heiltsuk Integrated Resource Management Department in Bella Bella, British Columbia. The HIRMD are in charge of overseeing the management of all natural resources in the Heiltsuk territory, including the beautiful and captivating sea wolves.  There is an air of magic and mystery about these sea swimming wolves that compel you to want to know, who are these beings and what is their story. William Housty tells us that story and what sea wolves mean to not only him, but to the Heiltsuk Nation.There are moments when you look into the eyes of another species and see into their being and know there is more… there is a story of life, suffering, and beauty, and a deep recognition and resonance. You know all at once you are not separate from or above them, but tied through a millennium of evolution and kinship. Thank you to William for inviting us into this story of the sea wolf. We are so grateful for the chance to listen and to see. Lots of Love.Show Notes: https://www.heiltsuknation.ca/

The guest host for today's show is Brad Bannon. Brad runs Bannon Communications Research, a polling, message development and media firm which helps labor unions, progressive issue groups and Democratic candidates win public affairs and political campaigns. His show, 'Deadline D.C. with Brad Bannon,' airs every Monday from 3-4pm ET. Brad is first joined by Kate Ackley, a Senior Reporter for Bloomberg Government. The two examine the impending government shutdown, which is set to happen October 1st.  Democrats seem less eager to bail out Republicans than they did at the beginning of the current Trump administration, drawing the line at new massive healthcare cuts which would drive up premiums 10-20% for folks with Affordable Care Act health plans. Then, Brad is joined by Dr. Bob Bollinger is the Raj and Kamla Gupta Professor of Infectious Diseases at the Johns Hopkins University School of Medicine. They examine the chaos caused at the CDC by RFK Jr. and the Trump administration, and the potentially dangerous new restrictions on who can now receive vaccines.   Dr. Bollinger holds joint appointments in International Health at the Johns Hopkins Bloomberg School of Public Health, and in Community Public Health at the JH School of Nursing. He has more than 45 years of experience in international public health, clinical research, and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic resistant infections, COVID-19 and other emerging diseases.  Dr. Bollinger is also Associate Director of the Center for Clinical Global Health Education (CCGHE). Their website is main.ccghe.net.  Brad writes a political column every Sunday for 'The Hill.' He's on the National Journal's panel of political insiders and is a national political analyst for WGN TV and Radio in Chicago and KNX Radio in Los Angeles. You can read Brad's columns at www.MuckRack.com/Brad-Bannon. His handle on BlueSky is @bradbannon.bsky.social.   (Image Credit: Jabin Botsford/The Washington Post/Getty Images)

In this episode of ChopTalk, we recognize National Hazing Prevention Week and explore Lambda Chi Alpha's longstanding commitment to creating a safe and supportive Brotherhood.Our guests, Jacob Mueller, Associate Director of Chapter Support, and Hailey Flavin, Director of Harm Reduction & University Relations, discuss Lambda Chi's history as one of the first fraternities to eliminate pledging, the ongoing work to prevent hazing, and how members and chapters can continue to lead by example.

Russia is one of the world's largest economies. It's a top energy exporter and a major supplier of wheat, fertilizers, wood, and metals. Since the invasion of Ukraine, Western governments have tried to squeeze Russia's revenues through unprecedented sanctions, price caps, and export controls. How Russia's economy responds to war and sanctions doesn't just matter for Moscow or Kyiv — it matters for the price of fuel in India, the cost of bread in Egypt, and the margins for factories in China.Understanding what's really going on in the Russian economy has become essential for anyone trying to design more painful sanctions or predict where global commodity prices are headed next. But what if our model of the Russian economy is fundamentally wrong?Nicholas Trickett is a political economist and writer who has spent years analysing the Russian economy. When he is not working on his forthcoming book, Empire of Austerity, Nick is covering the global mining and metals industry as an Associate Director at S&P Global.The Sanctions Age is hosted by Esfandyar Batmanghelidj. The show is produced by Spiritland Productions.To receive an email when new episodes are released, access episode transcripts, and read Esfandyar's notes on each episode, sign-up for the The Sanctions Age newsletter on Substack: https://www.thesanctionsage.com/

Visit us at Network2020.org. The United States has long been recognized as the global leader in artificial intelligence (AI), a technology transforming trade, foreign policy, and military strategy. China, once seen as years behind, is rapidly closing the gap, most recently with the launch of DeepSeek. With competition heating up in both chip technology and AI innovation, Washington has sought to maintain its edge through export controls and a recently unveiled AI Action Plan. As the world heads into a new technological era, will the U.S. be able to sustain its AI dominance? What advantages might allow Beijing to overtake Washington? And what are the ramifications for the rest of the world, particularly if there's a split into competing AI systems?Join us for a discussion with Janet Egan, Senior Fellow with the Technology and National Security Program at the Center for a New American Security, Owen J. Daniels is the Associate Director of Analysis and an Andrew W. Marshall Fellow at Georgetown's Center for Security and Emerging Technology (CSET); and Sam Winter-Levy, Fellow in the Technology and International Affairs Program at the Carnegie Endowment for International Peace. Music by Sergii Pavkin from Pixabay.

In this special episode on Obstructive Sleep Apnea our host, Dr. Neil Skolnik will discuss treatment of OSA. In Part 1 we discussed an overview of OSA, in Part 2 we discussed making the diagnosis, Part 3 was treatment, and in Part 4 we bring it all together with a case to explore clinical decision making for OSA. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Dr. Sanjay Patel, M.D, Professor of Medicine, Epidemiology, & Clinical and Translational Science, and Director of the Center for Sleep and Cardiovascular Outcomes Research; Medical Director of the Comprehensive Sleep Disorders Program, University of Pittsburgh Medical Center Susan Kuchera, M.D. - Clinical Associate Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University and Program Director of the Family Medicine Residency at Jefferson Health Abington. Selected references: Diagnosis and Management of Obstructive Sleep Apnea - A Review. JAMA. 2020;323(14):1389-1400 Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med 2024;391:1193-1205  

The landscape of American defense manufacturing has transformed dramatically since World War II—and not for the better. What happens when a nation with the world's most advanced military technology can't produce enough conventional artillery shells to supply Ukraine while maintaining its own reserves?This episode brings together three exceptional voices to examine America's critical vulnerability: our diminished industrial capacity. Arthur Herman, author of "Freedom's Forge," provides historical context on how America became the "arsenal of democracy" during WWII, when two-thirds of all Allied war materials came from American factories. Rand Simberg offers insights on how this manufacturing crisis affects the space industry, where China is rapidly closing the gap with American capabilities. Cameron Schiller, CEO of Rangeview, shares frontline experience trying to rebuild American manufacturing through advanced robotics.Their conversation reveals how decades of globalization created a nation with "a surplus of designers and a deficit in people who actually make real stuff." While America once had abundant workers with mechanical aptitude, today's workforce requires different approaches—highlighting SpaceX's role as an industrial "graduate school" teaching engineers how to build physical systems. The panel examines how vulnerable supply chains, dependent on foreign sources for critical components, create national security risks.The solution? A return to the "founder mentality" that prioritizes innovation over efficiency, rebuilding domestic supply chains, leveraging new technologies like AI and robotics, and cultivating a workforce skilled in modern manufacturing techniques. This isn't just about economics—it's about America's ability to project power and protect itself in an increasingly competitive world.Listen now to understand why, as Schiller puts it, "a nation that can't produce is a nation that can't project power."Support Our WorkThe Center for Demographics and Policy focuses on research and analysis of global, national, and regional demographic trends and explores policies that might produce favorable demographic results over time. It involves Chapman students in demographic research under the supervision of the Center's senior staff.Students work with the Center's director and engage in research that will serve them well as they look to develop their careers in business, the social sciences, and the arts. Students also have access to our advisory board, which includes distinguished Chapman faculty and major demographic scholars from across the country and the world.For additional information, please contact Mahnaz Asghari, Associate Director for the Center for Demographics and Policy, at (714) 744-7635 or asghari@chapman.edu.Follow us on LinkedIn:https://www.linkedin.com/company/the-feudal-future-podcast/Tweet thoughts: @joelkotkin, @mtoplansky, #FeudalFuture #BeyondFeudalismLearn more about Joel's book 'The Coming of Neo-Feudalism': https://amzn.to/3a1VV87Sign Up For News & Alerts: http://joelkotkin.com/#subscribeThis show is presented by the Chapman Center for Demographics and Policy, which focuses on research and analysis of global, national and regional demographic trends and explores policies that might produce favorable demographic results over time.

Join Drs. Neil Skolnik and Sara Wettergreen as they answer one of the most common questions people living with diabetes have: “What diabetes medication is best for me?”   In this episode, they'll explore how choosing the right medication depends on your individual health, lifestyle, and goals. Discover practical tips to better help you work with your care team to make informed decisions and find the best treatment plan for you.   Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Diabetes Medications: Biguanides Brand: Glucophage, Fortamet, Glumetza Generic: Metformin, Metformin XR Sulfonylureas (Second Generation) Brand: Glucotrol, Amaryl, Diaβeta, Glynase Generic: Glipizide, Glipizide XL, Glimepiride, Glyburide Thiazolidinediones (TZDs) Brand: Actos, Avandia Generic: Pioglitazone, Rosiglitazone (no longer available) DPP-4 Inhibitors Brand: Januvia, Onglyza, Tradjenta, Nesina Generic: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin SGLT2 Inhibitors Brand: Invokana, Farxiga, Jardiance, Steglatro, Brenzavvy Generic: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin, Bexagliflozin GLP-1 Receptor Agonists Brand: Victoza, Trulicity, Ozempic, Rybelsus, Mounjaro (dual GIP/GLP-1) Generic: Liraglutide, Dulaglutide, Semaglutide, Tirzepatide Insulins (selected examples) Brand: Humalog, NovoLog, Apidra, Lantus, Basaglar, Levemir, Tresiba, Humulin N, Novolin N, Humulin R, Novolin R Generic: Insulin lispro, Insulin aspart, Insulin glulisine, Insulin glargine, Insulin detemir, Insulin degludec, NPH insulin, Regular insulin

This week we're excited to present a special preview of the 63rd New York Film Festival, beginning next Friday, September 26 and running through October 13. Tickets to this year's festival are still available but going fast! NYFF Artistic Director Dennis Lim is joined by Jordan Raup, Associate Director of Marketing at Film at Lincoln Center, to break down the films and events you can't miss throughout this year's 17-day festival, including Anemone, BLKNWS: Terms & Conditions, Dry Leaf, Gavagai, Last Night I Conquered the City of Thebes, Sholay, Sirât, What Does That Nature Say to You, and more. Opening with Luca Guadagnino's After the Hunt, this year's festival will feature screenings across New York City's five boroughs, talks with your favorite filmmakers, stimulating panel discussions, trivia nights, and much more. Don't forget to subscribe here for more daily filmmaker conversations throughout the festival. Learn more at filmlinc.org/nyff

In this episode of the Building HVAC Science Podcast, Eric Kaiser and Bill Spohn welcome Lisa White, Associate Director of PHIUS, to explore the evolving world of passive building. Lisa shares her journey into building science, her role at PHIUS, and how the organization has grown from a niche movement into a force shaping multifamily and affordable housing projects across North America. She explains the core principles of passive building — thermal, air, and solar/radiation control — and how they translate into healthier, more comfortable, and more resilient spaces. Lisa also discusses PHIUS's training and certification programs, the importance of third-party verification, and how tools like WUFI Passive and PHPP guide design decisions. The conversation touches on the challenges of balancing technical rigor with real-world implementation, the role of embodied carbon in standards development, and how passive building benefits not only owners and occupants, but also the broader environment. Lisa closes with reflections on persistence, growth, and optimism for the future of better buildings.   “The details matter, but it's the greater goal and intent behind them that truly counts.” — Lisa White   “Passive building isn't about eliminating systems; it's about reducing the dependency on them.” — Lisa White   Design Around People, A Good Building Follows” — Robert Bean (quoted by Eric Kaiser)   Lisa shared a follow up thought after recording- her advice to younger self is "don't let perfect be the enemy of good -- while it's easy to get caught up in minor details, it's better to start by doing better and improve on that over time than to be held up by trying to be perfect at the onset.”   As well as-- “never pass up an opportunity to educate yourself or to collaborate with others.” She has learned that the best things come out of collaborative and open-minded conversations.  Lisa's LinkedIn: https://www.linkedin.com/in/lisa-white-7770226b/ PHIUS Website: www.PHIUS.org The High Performance Staircase: https://www.phius.org/sites/default/files/styles/1308xy/public/2024-05/staircase-to-success_v2_apr2024.png.webp?itok=veFnEiyu       This episode was recorded in August 2025.  

In this episode of Occupied Thoughts, FMEP Fellow Hilary Rantisi speaks with zehra imam, who launched Poetry of the Camps, a poetry program in Gaza with young writers. Basman Aldirawi and Duha Hassan Al Shaqaqi, former participants in the program who have become co-leaders of it, joined in the conversation. Basman and Duha shared what it meant for each of them to be writing poetry in Gaza during the genocide. They discussed the process of bringing students together virtually from all over the Gaza Strip, with different backgrounds and experiences, to write poetry. The themes of their sessions were miracles, homeland, the concept of colorism, love letters to Palestine, and freedom. They share a poem titled “Balsam” written by a student participant about her friend who was killed in the Israeli assault and discuss their experiences during the genocide: Basman, who was in Egypt on 10/7/23 and could not return to Gaza and Duha, who survived the genocide and was evacuated from Gaza just a few weeks ago. Basman Aldirawi (also published as Basman Derawi) is a physiotherapist and a graduate of Al-Azhar University in Gaza in 2010. Inspired by an interest in music, movies, and people with special needs, he contributes dozens of stories/poems to the online platform We Are Not Numbers and other platforms including Vivamost, Mondoweiss, ArabLit, and Written Revolution. He has contributed to the Arabic poetry anthology, Gaza: Land of Poetry, 2021 and to the English anthology, Light in Gaza: Writing Born in Fire, 2022. Basman was Illuminated Cities' inaugural Fall 2024 Poetry of the Camps-Gaza fellow. He is now part of the Illuminated Cities program team.  Duha Hassan Al Shaqaqi is a Palestinian writer, student, and storyteller who finds power in words, resilience in education, and purpose in advocacy. She was a 2024 inaugural Poetry of the Camps-Gaza fellow. Duha is now part of the Illuminated Cities program team, and her poem was featured in the 2025 Harvard Divinity School commencement speech. Raised in Gaza, she has experienced firsthand the challenges of war, displacement, and interrupted education — but also the strength of community, the value of knowledge, and the hope that creativity brings. With a background in English literature and a passion for humanitarian work, Duha writes about survival, identity, and the silent strength found in everyday moments. She has worked as a social worker during wartime and continues to pursue global education opportunities to amplify her voice and the voices of others. zehra imam is the founder of Illuminated Cities, an education organization that works on creative expression with communities impacted by systemic violence such as war or occupation. She designed Poetry of the Camps in 2024 for students in Gaza, Rohingya refugee camps, Harvard, and MIT and it continues to this day in Gaza and Rohingya refugee camps. Hilary Rantisi grew up in Palestine and has been involved with education and advocacy on the Middle East since her move to the US. She is a 2025 Fellow at FMEP and was most recently the Associate Director of the Religion, Conflict and Peace Initiative (RCPI) and co-instructor of Learning in Context: Narratives of Displacement and Belonging in Israel/Palestine at Harvard Divinity School. She has over two decades of experience in institution building at Harvard, having been the Director of the Middle East Initiative (MEI) at Harvard Kennedy School of Government prior to her current role. She has a BA in Political Science/International Studies from Aurora University and a master's degree in Middle Eastern Studies from the University of Chicago. Before moving to the US, Hilary worked at Birzeit University and at the Jerusalem-based Sabeel Ecumenical Liberation Theology Center. There, she co-edited a photo essay book Our Story: The Palestinians with the Rev. Naim Ateek. Original music by Jalal Yaquoub.

As part of our ongoing collaboration with Central Square Foundation, we are excited to bring to you the second episode of our five part series where we talk about the transformative journey of the NIPUN Bharat Mission.It has been four years since the launch of the Mission and for the first time in two decades we are seeing learning improvements among children. In this episode, we explore how the program has made significant strides in improving literacy and numeracy levels of students in Grades 1-3 across the country. And to get a deeper insight into the progress behind this Mission, we're joined by Parthajeet Das, Project Director for FLN, at CSF and Sambhrant Srivastava, Associate Director for FLN, who have been closely working with state departments of education of Haryana, Madhya Pradesh,Uttar Pradesh, Telangana, Assam, Punjab and Odisha, among other states.Hosted and produced by Niharika NandaEdited and mixed by Suresh PawarLink to the first episode of our series with CSF:Episode 2

Join our host Jane Caldwell for a discussion with Dr. Douglas Galasko, the Associate Director of the UC San Diego Shiley Marcos Alzheimer's Disease Research Center. Dr. Galasko will discuss the recently approved pTau217/β-Amyloid 1-42 plasma ratio test, the first blood biomarker test for Alzheimer's disease. He will talk about the role of this and other diagnostic tools, and what an early diagnosis can mean for patients and their families.Educational support provided by Fujirebio Diagnostics.Visit us at OnMedicalGrounds.com for more podcasts or download our app! You can subscribe through your podcast platform, our website, or follow us on social media for podcast updates and medical news. Some of our podcasts offer FREE CME/CE credits.LinkTreeBlueSkyLinkedInInstagram

ICYMI: Hour Two of ‘Later, with Mo'Kelly' Presents – Regular guest contributor & Associate Director of Communications for VIZIO, Chris Woolsey joins the program to share the latest offerings from VIZIO's ‘Watch Free+' including “September Comedies” with ‘Kindergarten Cop,' ‘Snatch,' and ‘Encino Man' & “Adventure Titles” with ‘Waterworld,' ‘Desperado,' and ‘In the Line of Fire'…PLUS – Thoughts on Actor, Comedian, Writer, Producer, TV Host and Radio Host Nick Cannon's admission that “having 12 kids was a response to trauma” - on KFI AM 640…Live everywhere on the iHeartRadio app & YouTube @MrMoKelly